Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P M Parikh

Showing results (111-120 of 129) with videos related to

Pageof 13
Sort By:
Cancer|August 1, 1989
Danazol in treatment of angio-immunoblastic lymphadenopathyS D Banavali, P M Parikh, B S Charak, et al.
American Journal of Hematology|March 8, 2013
Phase 2 study of subcutaneous omacetaxine mepesuccinate for chronic-phase chronic myeloid leukemia patients resistant to or intolerant of tyrosine kinase inhibitorsJ Cortes, R Digumarti, P M Parikh, et al.
Journal of Surgical Oncology|October 1, 1988
Treatment of Askin Rosai tumor--need for a more aggressive approachP M Parikh, B S Charak, S D Banavali, et al.
The Journal of the Association of Physicians of India|June 1, 1995
Role of growth factors in hastening hematopoietic recovery following HLA matched sibling allogeneic bone marrow transplantationP M Parikh, S Kulkarni, G Kapoor, et al.
Indian Journal of Cancer|June 1, 1989
Hodgkin's disease with bone marrow involvementR Gupta, P M Parikh, S H Advani, et al.
Cancer|June 4, 1998
A randomized comparison of the efficacy and toxicity of epirubicin and doxorubicin in the treatment of patients with non-Hodgkin's lymphomaR Nair, G Ramakrishnan, N N Nair, et al.
Medical Oncology (Northwood, London, England)|December 8, 2004
Two- vs three-drug combination chemotherapy in advanced or recurrent head and neck cancer: a single institution experience of 361 patientsV R Pai, A T Mazumdar, C D Deshmukh, et al.
The Journal of the Association of Physicians of India|May 3, 2006
Rituximab (anti-CD20 monoclonal antibody) in lymphoproliferative malignancies: Tata Memorial experienceG Biswas, P M Parikh, R Nair, et al.
South Asian Journal of Cancer|September 9, 2016
Lung cancer in India: Current status and promising strategiesP M Parikh, A A Ranade, Babu Govind, et al.
The Journal of the Association of Physicians of India|November 1, 1988
Splenomegaly and hepatomegaly at onset of blastic crisis in chronic myeloid leukaemia have prognostic importanceP M Parikh, B S Charak, S D Banavali, et al.
Pageof 13

Showing results (111-120 of 129) with videos related to

Sort By:
Pageof 13
Cancer|August 1, 1989
Danazol in treatment of angio-immunoblastic lymphadenopathyS D Banavali, P M Parikh, B S Charak, et al.
American Journal of Hematology|March 8, 2013
Phase 2 study of subcutaneous omacetaxine mepesuccinate for chronic-phase chronic myeloid leukemia patients resistant to or intolerant of tyrosine kinase inhibitorsJ Cortes, R Digumarti, P M Parikh, et al.
Journal of Surgical Oncology|October 1, 1988
Treatment of Askin Rosai tumor--need for a more aggressive approachP M Parikh, B S Charak, S D Banavali, et al.
The Journal of the Association of Physicians of India|June 1, 1995
Role of growth factors in hastening hematopoietic recovery following HLA matched sibling allogeneic bone marrow transplantationP M Parikh, S Kulkarni, G Kapoor, et al.
Indian Journal of Cancer|June 1, 1989
Hodgkin's disease with bone marrow involvementR Gupta, P M Parikh, S H Advani, et al.
Cancer|June 4, 1998
A randomized comparison of the efficacy and toxicity of epirubicin and doxorubicin in the treatment of patients with non-Hodgkin's lymphomaR Nair, G Ramakrishnan, N N Nair, et al.
Medical Oncology (Northwood, London, England)|December 8, 2004
Two- vs three-drug combination chemotherapy in advanced or recurrent head and neck cancer: a single institution experience of 361 patientsV R Pai, A T Mazumdar, C D Deshmukh, et al.
The Journal of the Association of Physicians of India|May 3, 2006
Rituximab (anti-CD20 monoclonal antibody) in lymphoproliferative malignancies: Tata Memorial experienceG Biswas, P M Parikh, R Nair, et al.
South Asian Journal of Cancer|September 9, 2016
Lung cancer in India: Current status and promising strategiesP M Parikh, A A Ranade, Babu Govind, et al.
The Journal of the Association of Physicians of India|November 1, 1988
Splenomegaly and hepatomegaly at onset of blastic crisis in chronic myeloid leukaemia have prognostic importanceP M Parikh, B S Charak, S D Banavali, et al.
Pageof 13